The negative outlook reflects the company's elevated leverage of above 4.0x. Although we expect the company to deliver strong results, which will allow it to lower leverage, we expect debt to EBITDA will remain elevated at roughly 3.0x over the next 12 months. We could lower the rating if large debt-funded initiatives, weaker-than-expected markets, or adverse regulatory changes weaken the company's credit measures. Specifically, we could lower the rating if: We expect debt to EBITDA to remain above 3.0x because of lower-than-expected profitability or an increase of debt-funded spending, or Operational issues or business mix push adjusted EBITDA margins closer to 15%. We could revise the outlook to stable in the next 12 months if the company reduces and sustains